Amy Fredrickson

Vocal Acoustic Biomarkers of Depression Severity and Treatment Response

Effects of a computer-based cognitive exercise program on age-related cognitive decline

Gut microbiome alterations in Alzheimer’s disease

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

The need to show minimum clinically important differences in Alzheimer's disease trials

Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model

Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease

Deficits in behavioural inhibition in substance abuse and addiction: A meta-analysis

Predicting Alzheimer disease from a blood-based biomarker profile

Dual Histamine H₃R/Serotonin 5-HT₄R Ligands with Antiamnesic Properties: Pharmacophore-Based Virtual Screening and Polypharmacology

Lecanemab in Early Alzheimer’s Disease

An update to the systematic literature review of empirical evidence of the impacts and outcomes of computer games and serious games

Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer’s Disease

Molecular Docking: Shifting Paradigms in Drug Discovery

The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease

A review of depression and suicide risk assessment using speech analysis

Rapid Decline in Episodic Memory in Healthy Older Adults with High Amyloid-β

Testing the Right Target and Right Drug at the Right Stage

Evaluation of the Usability of a Brief Computerized Cognitive Screening Test in Older People for Epidemiological Studies

Reliability, Stability, and Sensitivity to Change and Impairment in Acoustic Measures of Timing and Frequency

Cognitive recovery during and after treatment for volatile solvent abuse

The use of effect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine

Episodic Memory Decline Predicts Cortical Amyloid Status in Community-Dwelling Older Adults

P3‐046: Detection of memory decline in “healthy” community volunteers within 6 months

Intraindividual cognitive decline using a brief computerized cognitive screening test